Core Insights - The Federal Reserve maintained interest rates at 4.25%-4.5%, aligning with expectations [9] - The US GDP for Q2 grew by 3%, surpassing expectations, primarily due to a significant increase in net exports [11] - The A-share market shows strong revaluation momentum, with the CSI 300 index's historical PE and PB ratios at 12.3x and 1.24x, respectively, indicating a cheap valuation [9][11] Market Focus and Strategy - The A-share market is expected to have long-term value due to favorable policies, despite potential short-term adjustments [9] - Recommendations include gradually accumulating A-share ETFs due to valuation re-evaluation [9] - The Hang Seng Index experienced a significant drop, closing at 25,176 points, with analysts suggesting it may breach the 25,000 mark [13] Company Highlights - Meta Platforms Inc. reported a 36% year-on-year increase in net profit and a 22% rise in revenue for Q2, exceeding expectations [11] - HSBC has a pessimistic outlook on Hong Kong's commercial real estate, increasing provisions significantly [13] - The company Giant Bio (2367) is positioned as a leader in the collagen market, with a projected market size of 108.3 billion yuan by 2027 [21] Economic Data Overview - The US GDP growth rate for Q2 was reported at 3%, with PCE inflation at 2.1% [11] - China's manufacturing PMI for July is at 49.7, indicating contraction, while the non-manufacturing PMI is at 50.2, suggesting slight expansion [19] - Hong Kong's GDP growth for Q2 is reported at 2.8% year-on-year [19] Stock Recommendations - Buy recommendation for Giant Bio at $57.10, with a target price of $66.20 and a stop-loss at $54.72 [21] - Starbucks Corporation reported Q3 revenue of $9.456 billion, a 3.8% year-on-year increase, exceeding market expectations [23] - FTAI Aviation Ltd. saw a 52.4% year-on-year revenue increase to $676 million, indicating strong growth potential [24]